Home alone – depression highest for those living alone

 

London, UK (March 23, 2012) – The number of people living on their own has doubled, over the last three decades, to one in three in the UK and US. New research published in BioMed Central’s open access journal BMC Public Health shows that the risk of depression, measured by people taking antidepressants, is almost 80% higher for those living alone compared to people living in any kind of social or family group.

 

For women a third of this risk was attributable to sociodemographic factors, such as lack of education and low income. For men the biggest contributing factors included poor job climate, lack of support at the work place or in their private lives, and heavy drinking.

 

It is known that living alone can increase the risk of mental health problems for the elderly, and for single parents, but little is known about the effects of isolation on working-age people. Researchers in Finland followed 3500 working-aged men and women for seven years and compared their living arrangements with psychosocial, sociodemographic, and health risk factors, including smoking, heavy drinking and low physical activity, to antidepressant use. Information on antidepressant medication was taken from the National Prescription Register.

 

Dr Laura Pulkki-Råback, who conducted the research at the Finnish Institute of Occupational Health, explained, "Our study shows that people living alone have an increased risk of developing depression. Overall there was no difference in the increased risk of depression by living alone for either men or women. Poor housing conditions (especially for women) and a lack of social support (particularly for men) were the main contributory factors to this increased risk."

 

She continued, "This kind of study usually underestimates risk because the people who are at the most risk tend to be the people who are least likely to complete the follow up. We also were not able to judge how common untreated depression was."

 

While this study clearly identifies some of the factors which increase the risk of depression for people who live alone, over half the increase in risk is still unexplained. The researchers suggest that this may be due to feelings of alienation from society, lack of trust, or difficulties arising from critical life events. All these factors need to be addressed in order to begin understanding and reducing the incidence of depression amongst working age people.

 

 

Notes to Editors 

  1. Living alone and antidepressant medication use: a prospective study in a working-age population
    Laura Pulkki-Raback, Mika Kivimaki, Kirsi Ahola, Kaisla Joutsenniemi, Marko Elovainio, Helena Rossi, Sampsa Puttonen, Seppo Koskinen, Erkki Isometsa, Jouko Lonnqvist and Marianna Virtanen
    BMC Public Health (in press)
  2. BMC Public Health is an open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health. The journal has a special focus on the social determinants of health, the environmental, behavioral, and occupational correlates of health and disease, and the impact of health policies, practices and interventions on the community.
  3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector

 


 

BioMed Central (http://www.biomedcentral.com/), 23.03.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…